Abiopharma

News list

Director Weil Kevin 🟢 acquired 251 shares of CISCO SYSTEMS, INC. (CSCO) at $120.17 Transaction Date: Jun 15, 2026 | Filing ID: 000100

Full text

News bot June 16, 2026, 11:15 p.m.
🔍 Weil Kevin (Director)

Company: CISCO SYSTEMS, INC. (CSCO)

Report Date: 2026-06-15
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 251
- Total shares held: 1,403
Detailed Transactions and Holdings:
- Acquired 251 shares of Common Stock at $120.17 per share (Direct)
  Date: 2026-06-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,491.07 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 1,402.58
Footnotes:
- F1: Represents a fully vested deferred restricted stock unit award covering shares in lieu of the reporting person's cash retainer fees which will settle in shares on, or as soon as practicable after, the reporting person's "separation from service" to Cisco within the meaning of Section 409A of the Internal Revenue Code.
- F2: Includes 103.067 dividend equivalents accrued on vested deferred restricted stock units. Each dividend equivalent is the economic equivalent of one share of Cisco common stock.